Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $194.9900 (2.01%) ($190.5200 - $195.1700) on Fri. May. 18, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.28% (three month average) | RSI | 84 | Latest Price | $194.9900(2.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.8% a day on average for past five trading days. | Weekly Trend | LGND advances 11% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.14% in a week (0% probabilities). VXX(-16%) TLT(-15%) VIXM(-13%) UUP(-8%) GDXJ(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.14% (StdDev 2.28%) | Hourly BBV | 0 () | Intraday Trend | 1.8% | | | |
|
5 Day Moving Average | $189.19(3.07%) | 10 Day Moving Average | $178.78(9.07%) | 20 Day Moving Average | $168.34(15.83%) | To recent high | 0% | To recent low | 29.3% | Market Cap | $3.134b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |